JP2003512046A5 - - Google Patents

Info

Publication number

JP2003512046A5

JP2003512046A5 JP2001532180A JP2001532180A JP2003512046A5 JP 2003512046 A5 JP2003512046 A5 JP 2003512046A5 JP 2001532180 A JP2001532180 A JP 2001532180A JP 2001532180 A JP2001532180 A JP 2001532180A JP 2003512046 A5 JP2003512046 A5 JP 2003512046A5

Authority

JP

Japan

Prior art keywords

polypeptide

acid sequence

nucleic acid

seq

amino acid

Prior art date

2000-10-16

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 229920001184 polypeptide Polymers 0.000 description 26
• 102000004196 processed proteins & peptides Human genes 0.000 description 26
• 108090000765 processed proteins & peptides Proteins 0.000 description 26
• 150000007523 nucleic acids Chemical group 0.000 description 10
• 108091028043 Nucleic acid sequence Proteins 0.000 description 8
• 125000003275 alpha amino acid group Chemical group 0.000 description 7
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 4
• 150000001413 amino acids Chemical class 0.000 description 4
• 239000002773 nucleotide Substances 0.000 description 4
• 125000003729 nucleotide group Chemical group 0.000 description 4
• 230000000295 complement effect Effects 0.000 description 3
• 230000000694 effects Effects 0.000 description 3
• 238000004519 manufacturing process Methods 0.000 description 3
• 108020004707 nucleic acids Proteins 0.000 description 3
• 102000039446 nucleic acids Human genes 0.000 description 3
• 241000589596 Thermus Species 0.000 description 2
• 239000003599 detergent Substances 0.000 description 2
• 238000000034 method Methods 0.000 description 2
• 229920000310 Alpha glucan Polymers 0.000 description 1
• 241000588724 Escherichia coli Species 0.000 description 1
• 229920001503 Glucan Polymers 0.000 description 1
• 108020005038 Terminator Codon Proteins 0.000 description 1
• 238000012258 culturing Methods 0.000 description 1
• 125000004122 cyclic group Chemical group 0.000 description 1
• 238000012217 deletion Methods 0.000 description 1
• 230000037430 deletion Effects 0.000 description 1
• 239000013604 expression vector Substances 0.000 description 1
• 238000011534 incubation Methods 0.000 description 1
• 238000003780 insertion Methods 0.000 description 1
• 230000037431 insertion Effects 0.000 description 1
• 239000008363 phosphate buffer Substances 0.000 description 1
• 239000013612 plasmid Substances 0.000 description 1
• 238000003259 recombinant expression Methods 0.000 description 1
• 230000001105 regulatory effect Effects 0.000 description 1
• 238000006467 substitution reaction Methods 0.000 description 1
• 239000000758 substrate Substances 0.000 description 1
• 238000013518 transcription Methods 0.000 description 1
• 230000035897 transcription Effects 0.000 description 1
• 238000005918 transglycosylation reaction Methods 0.000 description 1